Trial intelligence / Profile preview

PhytoSERM in peri- and postmenopausal women

NCT05664477Phase 2Active, not recruiting

Start
Jan 2024
Primary completion
Jan 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of PhytoSERM in menopause. Started Jan 2024; status: active, not recruiting.

02

Drugs

PhytoSERM
03

Conditions

menopause

Beyond the preview

Go deeper on NCT05664477.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05664477.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call